During a clinical trial, which procedures should the investigator follow?

Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

Multiple Choice

During a clinical trial, which procedures should the investigator follow?

Explanation:
In a clinical trial, investigators must follow the protocol’s predefined procedures, including how participants are randomized. Adhering to the trial’s randomisation procedures ensures allocation is unbiased, maintains allocation concealment, and preserves the integrity of the comparison between treatment groups. The investigator’s duty is to implement the randomization exactly as specified, document assignments, and not alter the process. The sponsor’s marketing plan is outside the conduct of the trial, participants’ personal preferences cannot override the protocol, and while a site equipment maintenance schedule is important for safety and data quality, it is not the set of trial procedures that governs how participants are randomized or treated.

In a clinical trial, investigators must follow the protocol’s predefined procedures, including how participants are randomized. Adhering to the trial’s randomisation procedures ensures allocation is unbiased, maintains allocation concealment, and preserves the integrity of the comparison between treatment groups. The investigator’s duty is to implement the randomization exactly as specified, document assignments, and not alter the process. The sponsor’s marketing plan is outside the conduct of the trial, participants’ personal preferences cannot override the protocol, and while a site equipment maintenance schedule is important for safety and data quality, it is not the set of trial procedures that governs how participants are randomized or treated.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy